Valion Bio, Inc. SEC filings VBIO

Valion Bio, Inc. has 403 filings in SEC EDGAR's recent list, going back to Sep 10, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Antonio, TX
SEC filer status
, Emerging growth company
SEC CIK
1787740
Former names
Tivic Health Systems, Inc. (until Apr 23, 2026)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.